Regulation of T cell-mediated hepatic inflammation by adiponectin and leptin

Endocrinology

Volumn 146, Issue 5, 2005, Pages 2157-2164

  Sennello, Joseph A ^a,d   Fayad, Raja ^a,d   Morris, Alison M ^a,e   Eckel, Robert H ^a   Asilmaz, Esra ^b   Montez, Jason ^b   Friedman, Jeffrey M ^b,c,f   Dinarello, Charles A ^a   Fantuzzi, Giamila ^a,d  

^a UNIVERSITY OF COLORADO   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^f Chromocell Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CONCANAVALIN A; GALACTOSAMINE; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; FEMALE; HEPATITIS; IN VIVO STUDY; LIPODYSTROPHY; LIVER CELL; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; WHITE ADIPOSE TISSUE;

ADIPONECTIN; ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; CCAAT-ENHANCER-BINDING PROTEINS; CONCANAVALIN A; CYTOKINES; DNA-BINDING PROTEINS; HEPATITIS; IN SITU NICK-END LABELING; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; LEPTIN; LIPODYSTROPHY; LYMPHOCYTE ACTIVATION; MICE; MICE, OBESE; MICE, TRANSGENIC; OBESITY; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; T-LYMPHOCYTES; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 17744367852     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-1572     Document Type: Article

References (32)

1. Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ, Burrell MA 2001 The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol 280:E827-E847
2. Fantuzzi G, Faggioni R 2000 Leptin in the regulation of immunity, inflammation and hematopoiesis. J Leukocyte Biol 68:437-446
3. Rajala MW, Scherer PE 2003 The adipocyte: at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144:3765-3773
4. Beltowski J 2003 Adiponectin and resistin: new hormones of white adipose tissue. Med Sci Monit 9:RA55-RA61
5. Chinetti G, Zawadski C, Frachart JC, Staels B 2004 Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARα, PPARγ and LXR. Biochem Biophys Res Commun 314:151-158
6. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H 2004 Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 15:630-635
7. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y 1999 Novel modulator for endothelial adhesion molecules. Adipocyte-derived plasma protein adiponectin. Circulation 100:2473-2476
8. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y 2000 Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 102:1296-1301
9. Rakatzi I, Mueller H, Ritzeler O, Tennagels N, Eckel J 2004 Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic β-cell line INS-1. Diabetologia 47:249-258
10. Lin LY, Lin CY, Su TC, Liau CS 2004 Angiotensin II-induced apoptosis in human endothelial cells is inhibited by adiponectin through restoration of the association between endothelial nitric oxide synthase and heat shock protein 90. FEBS Lett 574:106-110
11. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T, Matsuzawa Y 2004 Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94:e27-e31
12. Masaki T, Chiba S, Tatsukawa T, Noguchi H, Seike M, Yoshimatsu H 2004 Adiponectin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice. Hepatology 40:177-184
13. Xu A, Wang Y, Keshaw H, Xu LY, Lam KSL, Cooper GJS 2003 The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112:91-100
14. Kamada Y, Tamura S, Kiso S, Matsumoto H, Saji Y, Yoshida Y, Fukui K, Maeda N, Nishizawa H, Nagaretani H, Okamoto Y, Kihara S, Miyagawa J, Shinomura Y, Funahashi T, Matsuzawa Y 2003 Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 125:1796-1807
15. Faggioni R, Jones-Carson J, Reed DA, Dinarello CA, Feingold KR, Grunfeld C, Fantuzzi G 2000 Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor-α and IL-18. Proc Natl Acad Sci USA 97:2367-2372
16. Matarese G, Di Giacomo A, Sanna V, Lord GM, Howard JK, Di Tuoro A, Bloom SR, Lechler RI, Zappacosta S, Fontana S 2001 Requirement for leptin in the induction of autoimmune encephalomyelitis. J Immunol 166:5909-5916
17. Busso N, So A, Chobaz-Peclat V, Morard C, Martinez-Soria E, Talabot-Ayer D, Gabay C 2002 Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 168:875-882
18. Siegmund B, Lehr HA, Fantuzzi G 2002 leptin: a pivotal mediator of intestinal inflammation. Gastroenterology 122:2011-2025
19. Siegmund B, Lear-Kaul KC, Faggioni R, Fantuzzi G 2002 Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis. Eur J Immunol 32:552-560
20. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G 1995 Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21:190-198
21. Ksontini R, Colagiovanni DB, Josephs MD, Edwards III CK, Tannahill CL, Solorzano CC, Norman J, Denham W, Clare-Salzler M, MacKay SL, Moldawer LL 1998 Disparate roles for TNF-α and Fas ligand in concanavalin A-induced hepatitis. J Immunol 160:4082-4089
22. Takeda K, Hayakawa Y, Van Kaer L, Matsuda H, Yagita H, Okumura K 2000 Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 97:5498-5503
23. Shimomura I, Hammer RE, Richardson JA, Ikemoto S, Bashmakov Y, Goldstein JL, Brown MS 1998 Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev 12:3182-3194
24. Shimomura I, Hammer RE, Ikemoto S, Brown MS, Goldstein JL 1999 Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 401:73-76
25. Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A 2002 Leptin-replacement therapy for lipodystrophy. N Engl J Med 346:570-578
26. Montez JM, Soukas AA, Asilmaz E, Fayzikhodjaeva G, Fantuzzi G, Friedman JE, Acute leptin deficiency, leptin resistance and the physiologic response to leptin withdrawal. Proc Nat Acad Sci USA, in press
27. Leist M, Gantner F, Jilg S, Wendel A 1995 Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 154:1307-1316
28. Haluzik M, Colombo C, Gavrilova O, Chua S, Wolf N, Chen M, Stannard B, Dietz KR, Le Roith D, Reitman ML 2004 Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Endocrinology 145:3258-3264
29. Asilmaz E, Cohen P, Miyazaki M, Dobrzyn P, Ueki K, Fayzikhodjaeva G, Soukas AA, Kahn CR, Ntambi JM, Socci ND, Friedman JM 2004 Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. J Clin Invest 113:414-424
30. Tiegs G 1997 Experimental hepatitis and role of cytokines. Acta Gastroenterol Belg 60:176-179
31. Jaruga B, Hong F, Sun R, Radaeva S, Gao B 2003 Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J Immunol 171:3233-3244
32. Cohen P, Zhao C, Cai X, Montez JM, Rohani SC, Feinstein P, Mombaerts P, Friedman JM 2001 Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest 108:1113-1121